J. Taylor Wharton

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines.

Bryan Fisk, Tana Blevins, J. Taylor Wharton et al. · The Journal of Experimental Medicine · 1995 · 542 citations · Full text

Life Sciences, Immunology, Oncology +17

Quality of Life and Sexual Functioning in Cervical Cancer Survivors

Michael Frumovitz, Charlotte C. Sun, Leslie R. Schover et al. · Journal of Clinical Oncology · 2005 · 421 citations

Medicine, Oncology, Surgery +16

Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix

Patricia J. Eifel, C. Levenback, J. Taylor Wharton et al. · International Journal of Radiation Oncology*Biology*Physics · 1995 · 406 citations

Medicine, Oncology, Radiation Oncology +11

Intraabdominal Lymphatic Mapping to Direct Selective Pelvic and Paraaortic Lymphadenectomy in Women with High- Risk Endometrial Cancer: Results of a Pilot Study

Thomas W. Burke, Charles Levenback, Carmen Tornos et al. · Gynecologic Oncology · 1996 · 367 citations

Medicine, Oncology, Surgery +16

Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer

Charlotte C. Sun, Diane C. Bodurka, C. B. Weaver et al. · Supportive Care in Cancer · 2004 · 300 citations

Medicine, Oncology, Pharmacotherapy +17